Home
About Us
Company Profile
General Manager's Speech
Honor Qualification
News
Company News
Industry News
Product
General surgery
Gynecology
Beauty equipment
E.N.T department
Urology
Orthopedics
Accessories
Case
Contact Us
Industry Information
2019 ASCO | Research progress of circulating tumor cells CTCs in tumor immunotherapy
From May 31 to June 4, 2019, the 55th ASCO annual meeting will continue to gather in Chicago. The theme of this year's meeting is: ASCO conference content has many research progress on liquid biopsy. Today, we will look at relevant reports on CTCs of circulating tumor cells in immunotherapy and tumor immunology through ASCO conference. I.
11-23
2023
Analysis of National Medical Devices from 2017 to 2018
Chinese Anti-Cancer Association Tumor Marking Professional Committee CTC Technical Expert Committee was established!
On the evening of September 13, on the eve of the opening of the "2018 China Tumor Markers Academic Conference and the 12th Tumor Markers Young Scientists Forum", the National Committee of the Cancer Markers Professional Committee of the Chinese Anti-Cancer Association and the Youth Committee were successfully held. Professor Wang Ying, Secretary-General of the Chinese Anti-Cancer Association, Professor Xing Jinliang, Chairman of the Cancer Marking Professional Committee of the Chinese Anti-Cancer Association, Professor Shan Baoen, Deputy Chairman of the Cancer Marking Professional Committee of the Chinese Anti-Cancer Association, Professor Zeng Musheng, Professor Xie Xiaodong, Professor Wang Dong, and Youth Committee Chairman Professor Wang Shukui was seated on the rostrum. The meeting was organized by the fourth hospital of Hebei medical university, vice chairman of the special committee.
10-04
2018
CTC technology hammer sound: experts will develop industry standards
In recent years, a non-invasive detection method called liquid biopsy is changing the diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy has the characteristics of dynamic, real-time, easy to obtain samples, light pain and low risk. This technology was once named "Top Ten Breakthrough Technologies of 2015" by MIT Technology Review ". In recent years, the commercial value of liquid biopsy showed explosive growth. Illumina CEO Jay Flatley has said the liquid biopsy market is worth at least $40 billion. He believes that this technology may be an exciting breakthrough in the field of cancer diagnosis.